Memorial Sloan Kettering Cancer Center’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $3.64M | Hold |
602,272
| – | – | 14.84% | 2 |
|
|
2023
Q2 | $4.67M | Hold |
602,272
| – | – | 14.75% | 2 |
|
|
2023
Q1 | $3.43M | Hold |
602,272
| – | – | 10.53% | 2 |
|
|
2022
Q4 | $3.55M | Hold |
602,272
| – | – | 11.7% | 2 |
|
|
2022
Q3 | $1.93M | Hold |
602,272
| – | – | 6.55% | 4 |
|
|
2022
Q2 | $2.7M | Hold |
602,272
| – | – | 8.92% | 4 |
|
|
2022
Q1 | $3.22M | Hold |
602,272
| – | – | 3.72% | 4 |
|
|
2021
Q4 | $8.85M | Hold |
602,272
| – | – | 5.56% | 4 |
|
|
2021
Q3 | $12.6M | Hold |
602,272
| – | – | 7.85% | 4 |
|
|
2021
Q2 | $10.7M | Hold |
602,272
| – | – | 6.97% | 3 |
|
|
2021
Q1 | $14.8M | Hold |
602,272
| – | – | 9.09% | 3 |
|
|
2020
Q4 | $20.4M | Buy |
+602,272
| New | +$20.4M | 8.63% | 3 |
|